However, RBC Capital has reiterated that Vertex could require stronger execution to adopt Alyftrek to justify the current ...

As Dr. Geary transitions out of his role, he will continue as a strategic consultant through 2026 to ensure continuity. Ionis ...

The HHS said center directors deserve to be supported by managers aligned with aggressive goals “to expeditiously advance ...

Parataxis is launching a Bitcoin treasury platform for South Korean institutional investors, which saw Bridge Bio’s stock ...

Beam Therapeutics shows promising BEACON trial results in SCD, backed by strong cash reserves and pipeline momentum. See why ...

GLP-1 drugs are revolutionizing the treatment of obesity and diabetes. Here's what to know about investing in GLP-1 stocks.

UroGen Pharma posted 0% EPS growth in the latest quarterly report, while sales growth came in at 8%. The company earns the No ...

The Bajaj Auto Ltd board had recommended a final dividend of Rs 210 per share for FY25. Friday is the record date for the ...

Investing.com -- Capricor Therapeutics Inc (NASDAQ: CAPR) stock tumbled 20.4% following news that two top FDA officials overseeing cell and gene therapies have been placed on administrative leave.

FST Corp's sales spike when golfers use FST equipment to win major tournaments. Rising expenses outpace revenue growth, ...

Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin” or the "Company”), a late-stage pharmaceutical company with a broad ...

This week’s Bulls N’ Bears ASX Runners of the Week is… Amplia Therapeutics. The biotech beauty might just be onto a fabled ...